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INTRODUCTION
Extensive use of broad-spectrum antibiotics has led to the development and spread of extensively antibiotic-resistant strains of bacteria, making antimicrobial resistance a global problem. Antibioticresistant bacteria kill 25,000 people in the EU every year. Infections such as urinary tract infections [1] , pneumonia [2] and septicemia [3] are increasingly associated with multi-drug resistant Gramnegative bacteria in all regions of the world [4] . These antibiotic-resistant bacteria generally cause infections associated with increased risk of poor clinical outcome and mortality compared to nonresistant strains of the same bacteria [5] . The World Health Organization warns that antimicrobial resistance is an increasingly serious threat to global public health and calls for action across all government sectors and society [6] to avoid a dreaded "post-antibiotic" era.
A recent rekindling of antibiotic research has shown that the antimicrobial peptide class of antibiotics is particularly promising for use against infections caused by multidrug-resistant microorganisms [7] [8] [9] . Antimicrobial peptides (AMPs) are an important component of the natural defenses of most living organisms, and more than 2500 AMPs have been registered in the Antimicrobial Peptide Database (http://aps.unmc.edu/AP/main.php) [10] . However, despite their desirable characteristics, antimicrobial peptides have had limited pharmaceutical development due to their toxicity, instability and manufacturing costs, and therefore only a few AMPs have actually been approved for clinical use [11] [12] .
The most common mechanism of antimicrobial killing by antimicrobial peptides is disruption of the cytoplasmic membrane, for example by pore formation, which is rather non-specific but highly efficient [13] [14] [15] . Alternative mechanisms of action include peptide translocation into the cytoplasm where the antibiotic interferes with bacterial metabolic processes, such as protein synthesis or DNA replication, while other peptides are known to interact directly with specific membrane components [16] [17] [18] . In particular, cationic AMPs have been demonstrated to induce anionic lipid clustering which appears to arrest bacterial growth or trigger cell death [19] [20] .
SET-M33 is an antimicrobial peptide that has been extensively studied in recent years [21] [22] [23] [24] [25] . It is a cationic non-natural peptide built in a branched form ( Figure 1 ) that makes it more resistant to degradation in biological fluids [26] . SET-M33 has shown efficacy against a number of Gramnegative multi-drug and extensively drug-resistant clinical isolates [21, 24] . It has also shown acceptable toxicity in human cells and in mice [22] , as well as anti-inflammatory activity [23] .
Nevertheless, its mechanism of action has not yet been researched in depth. In this study we used different techniques to study the mechanism of action of SET-M33 against two Gram-negative bacterial species, K. pneumoniae and P. aeruginosa: 1) bacterial killing kinetics over time to see
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ACCEPTED MANUSCRIPT 4 concentration-dependency and onset of resistance; 2) electron microscopy imaging of treated bacteria to visualize membrane disturbance; 3) hemolytic activity to assess eukaryotic cell toxicity and 4) NMR and circular dichroism to study the structure of the peptides in the presence of micelles and their ability to stabilize in a facial amphiphilic helix.
Figure 1. Structure of SET-M33

MATERIALS AND METHODS
Peptide synthesis
All peptides were prepared by solid-phase synthesis through standard Fmoc chemistry using a Syro multiple peptide synthesizer (MultiSynTech, Witten, Germany). Side chain protecting groups were 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl for R, t-butoxycarbonyl for K and t-butyl for S (Iris Biotech GmbH, Marktredwitz, Germany 
Concentration-and time-dependent bactericidal activity of SET-M33 and colistin -TKK assay
The concentration-and time-dependent killing capacity of SET-M33 was determined using timekill kinetic (TKK) assays, as previously described [29] . Briefly, stationary-phase MH-II broth cultures of K. pneumoniae R-DYK 4861 and P. aeruginosa B-162 were diluted in 25 ml MH-II broth until a density of approximately 7×10 5 colony forming units (CFU/ml) was achieved.
Bacterial cultures were exposed to antimicrobial antibiotics at 2-fold increasing concentrations for 24 h at 37°C under shaking conditions at 96 rpm at 37ºC. Next, 1 mL samples were taken at 0, 1, 2, 4, 6 and 24 h of antibiotic exposure and centrifuged at 12500 xg for 5 min to pellet the cells, which were then resuspended in sterile PBS. Agar plates were incubated for 24 h (K. pneumoniae) or 48 h (P. aeruginosa) at 37C in order to determine the number of CFU. The lower limit of quantification in this assay was 5 CFU/mL (log 0.7). For colistin-susceptible bacterial isolates, the two-fold antibiotic concentration range was 0.125-64 mg/L for SET-M33 and colistin alike. For colistinresistant isolates, the two-fold antibiotic concentration range was 0.125-64 mg/L for SET-M33 and 1-512 mg/L for colistin. Flasks showing re-growth of bacteria after 24 h antibiotic exposure were examined for changes in antibiotic susceptibility using the antibiotic MIC assay described above, but with an antibiotic concentration range of 0.5-512 mg/L for the colistin-resistant isolates.
Sample preparation for electron microscopy
P. aeruginosa PAO1 and K. pneumoniae ATCC 13833 cells in logarithmic phase were resuspended at 2 × 10 8 CFU/ml in PBS and incubated with 1.5 µM SET-M33 at room temperature for 15, 30 and 60 min. The mixture was then centrifuged for 5 min at 10 000 r.p.m.
Scanning electron microscopy
Centrifuged bacteria were resuspended in 500 µl PBS and a drop of liquid cell suspension was placed on untreated glass coverslip for five minutes. The coverslip was then fixed for immersion in 2.5% glutaraldehyde solution in phosphate buffer 0.1 M pH 7.2 (PB) for 2 h at 4°C, washed in PB,
postfixed in 1% OsO 4 in PB for 30 min at 4°C, dehydrated in an ascending alcohol series, and dried in a Balzers CPD 030 CO 2 critical point dryer.
The coverslip was then mounted on an aluminum stub, coated with 20 nm gold in a Balzers MED010 sputtering device, and observed in a Philips XL20 scanning electron microscope with an electron accelerating voltage of 20 kV.
Transmission electron microscopy
Centrifuged bacteria were fixed in 2.5% glutaraldehyde solution in phosphate buffer 0. 
Nuclear magnetic resonance
All NMR samples were prepared by dissolving lyophilized peptides in 500 µl H 2 O/D 2 O (95:5) to a final concentration of 1.0 mM, with the exception of SET-M33, which was dissolved to a final concentration of 0.25 mM. Since the resonance of N-terminus amide would be missed in aqueous media due to chemical exchange, the peptide sequence of the Q-33 peptide, bearing a leading glutamine [33] [34] , was used instead, allowing us to gain structural information on the Lys1 residue.
Samples with micelles were prepared using 100 mM fully deuterated sodium dodecyl sulfate (SDS-d25, Cambridge Isotopes). Paramagnetic spectra were recorded with 2.5 mM Gd(III)(DTPA-BMA).
All spectra were acquired on a Bruker DRX Avance spectrometer operating at 14. San Francisco) while calibration of NOE peak volumes, distance calculation and restrained torsion angle dynamics for structure calculation were performed using Dyana [30] .
Circular dichroism
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ACCEPTED MANUSCRIPT 8 CD spectra were recorded at 25°C with a Jasco 815 spectropolarimeter using quartz cells having a path length of 0.1-cm. SET-M33 (100 M) or Q-33 (100 M) were dissolved in pure water or 30 mM SDS. The results were processed with the application Spectra Manager II™ Suite .
Hemolytic activity
The ability of SET-M33 peptide to induce hemolysis of human red blood cells was assessed. Whole blood (EDTA) was centrifuged (1100 xg) for 10 min. Red blood cells diluted 1:100 in PBS were incubated for 24 h at 37°C in PBS with two-fold serial dilution of all peptides from 4 mg/L to 1.8 g/L. The absorbance of the supernatants was determined in a 96-well plate at 490 nm using a microplate reader. Date for 100% hemolysis was obtained by adding 0.1% Triton X-100 in water.
The negative control was PBS. The hemolysis rate of each peptide was calculated with the 
RESULTS AND DISCUSSION
The K. pneumoniae and P. aeruginosa isolates used in the following experiments were resistant to a wide range of beta-lactam antibiotics (penicillins, cephalosporins and carbapenems) including the 4 th generation cephalosporin cefepime, aminoglycosides (gentamycin and tobramycin) and
fluoroquinolones (ciprofloxacin and norfloxacin). Interpretation of antimicrobial susceptibility was based on European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2014 guidelines [28] .
Susceptibility of bacterial isolates to SET-M33 and colistinminimum inhibitory concentration MIC
The susceptibility of the colistin-susceptible K. pneumoniae B-DYK 4861 and P. aeruginosa B-162
isolates and their colistin-resistant mutants to SET-M33 and colistin in terms of MIC are shown in Table 1 . Colistin resistance did not affect SET-M33 susceptibility in these two strains, confirming our previous data on seven different colistin-resistant K. pneumoniae strains [21] .
SET-M33 showed a MIC of 8 mg/L for K. pneumoniae ATCC 13833 and P. aeruginosa PAO1 [21] . Colistin-susceptible and colistin-resistant K. pneumoniae isolates were killed by ≥99.9% after 2 h of exposure to ≥4 mg/L and ≥8 mg/L SET-M33, respectively (the first concentration above the grey shade in Figure 2A , B). This was followed by bacterial re-growth up to the level of non-exposed bacteria after 24 h exposure to ≤4 mg/L and ≤16 mg/L, respectively. Colistin killed ≥99.9% of the colistin-susceptible K. pneumoniae isolate after 2 h of exposure to ≥0.5 mg/L ( Figure 2C ) and bacterial re-growth after 24 h exposure was observed up to ≤32 mg/L.
SET-M33 and colistin activity against colistin
In the colistin-resistant isolate, colistin concentration-dependent killing was observed in the first hour of exposure but ≥99.9% killing was not achieved after 2 h of exposure ( Figure 2D ). 
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ACCEPTED MANUSCRIPT 11 For P. aeruginosa, ≥99.9% killing was achieved in colistin-susceptible and colistin-resistant isolates after 2 h of exposure to ≥8 mg/L SET-M33 ( Figure 2E and 2F) .
Colistin killed ≥99.9% of bacteria in the colistin-susceptible P. aeruginosa isolate after 2 h of exposure to a concentration ≥1 mg/L ( Figure 2G ). In the colistin-resistant P. aeruginosa isolate, colistin concentration-dependent killing was observed in the first 2 h of exposure, followed by bacterial re-growth up to the level of non-exposed bacteria after 24 h, at all the colistin concentrations tested ( Figure 2H ).
We also showed that exposure to SET-M33 sterilized colistin-susceptible K. pneumoniae and P.
aeruginosa populations already at one-fold (16 mg/L) ( Figure 2A ) and four-fold (64 mg/L) ( Figure   2E ) the MICs, respectively. In contrast, after exposure to colistin, sterilization only occurred at the extremely high concentration of 64 mg/L ( Figure 2C and 2G) , which is 128-fold and 32-fold the MICs of colistin-susceptible K. pneumoniae and P. aeruginosa, respectively. Colistin-resistant K.
pneumoniae and P. aeruginosa were sterilized with 64 mg/L SET-M33 ( Figure 2B and 2F) in both cases (four-fold the MIC) but never with colistin ( Figure 2D and 2H ).
SET-M33 and colistin showed concentration-dependent bactericidal activity against colistinsusceptible and colistin-resistant isolates of K. pneumoniae and P. aeruginosa. This result is similar to the action of different widely used antibiotics e.g. aminoglycosides and fluoroquinolones, as well as other AMPs [31] .
SET-M33 retains activity against both colistin-susceptible and colistin-resistant bacteria. This result
indicates that SET-M33 is impervious to the mechanisms associated with colistin resistance.
Selection of resistance
Selection of resistance was assessed in the same experiments: when re-growth was observed after 24 h of exposure to antibiotic, bacterial susceptibilities were determined as MIC. Re-growth of colistin-susceptible strains of K. pneumoniae and P. aeruginosa after 24 h of exposure to SET-M33 was never associated with selection of SET-M33 resistance ( Table 2 ): in fact, MIC values did not increase more than 0.5-2 fold, whereas re-growth of K. pneumoniae after 24 h of colistin exposure was associated with decreased susceptibility and a manifold increase in MIC (Table 2 ). Colistin was more effective against P. aeruginosa, although bacteria regrowing at 1 mg/L colistin showed a ~sixfold increase in MIC.
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Similar results were obtained with the colistin-resistant strains, although re-growth of colistinresistant K. pneumoniae showed slightly lower susceptibility to SET-M33 with a four-fold increase in MIC (Table 2S Supplementary data) . Colistin-susceptible bacterial cultures were exposed to two-fold increasing concentrations of SET-M33 or colistin for 24 h at 37 o C under shaking conditions. When bacteria re-grew after 24 h exposure to antibiotic, their MIC susceptibilities (performed in triplicate) were also determined and the median value reported. NR, no bacterial re-growth. 1 One out of three samples did not show bacterial re-growth. 2 Two out of three samples did not show bacterial re-growth.
Gram-negative bacteria can reduce their susceptibility to AMPs by reducing their net negative surface charges, modifying capsule polysaccharides, or reducing outer membrane fluidity [32] . In contrast to colistin, resistance to SET-M33 does not readily develop during 24 hours of continuous exposure. This finding provides evidence that some of the resistance mechanisms that affect colistin do not affect SET-M33 to the same extent. For example, the mutations that lead to colistin resistance may not have the same effect on the activity of SET-M33, or alternatively, exposure to SET-M33 may not elicit the type of resistance mutations that are selected or induced by colistin.
Ways of avoiding resistance will be investigated in further studies. Importantly, the fact that resistance to SET-M33 does not appear within 24 exposure period to the antibiotic provides evidence that the use of SET-M33 in the clinic may have advantages over the use of colistin. For
ACCEPTED MANUSCRIPT 13 example, colistin is currently used as an antibiotic of last resort for MDR bacteria [33] [34] , but besides its toxic side effects, it is also becoming dangerously more often ineffective due to increasing number of resistant strains [35] [36] [37] .
Electron microscopy
The effect of SET-M33 treatment at MIC (8 mg/L SET-M33) for 15, 30 and 60 min on bacterial cell morphology was studied by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). SEM images showed that after 30 min of SET-M33 treatment, the surfaces of K. pneumoniae ATCC 13833 and P. aeruginosa PAO1 cells lost their smoothness and developed superficial blisters (Figure 3 ). After 60 min of SET-M33 treatment, bacterial cells appeared larger than control cells and many were empty and showed large holes, mainly at the poles. In the first 30 minutes after incubation with SET-M33, only a few K. pneumoniae and P. aeruginosa bacterial cells (rare in the micrograph field) showed cell damage.
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ACCEPTED MANUSCRIPT 15 Some linear peptides are reported to kill bacteria very quickly [16] , while others, such as magainin-2, kill bacteria after 15-90 min. SET-M33 damages bacteria in the latter time range: indeed microscopy only showed initial signs of bacterial membrane disturbance in very few cells after 10-15 min of exposure. With longer exposure, the damage to bacterial membranes increased in frequency and severity.
Peptide conformation -NMR structure analysis and circular dichroism
The supramolecular structure of peptides is important and has been extensively studied in interactions of peptides with bacterial membranes [16, [38] [39] . The NMR spectra of free SET-M33 showed a chemical shift index typical of a random coiled conformation and no significant interresidue NOEs, indicating that the peptide explores a large conformational space. On addition of sodium dodecyl sulfate (SDS) micelles, the NMR spectrum of SET-M33 undergoes a generalized broadening, caused by the production of slow-tumbling high-mass species, precluding further analysis. The high-mass species could be aggregates of SET-M33-SDS, possibly promoted by the multimericity of SET-M33. We therefore synthesized an analogue peptide, Q-33, in linear form and capped it with an additional amino acid (Q-KKIRVRLSA) at the N-terminus in order to generate a model of SET-M33 that could be studied in the presence of SDS. Q-33 has an extremely lower half life in serum and plasma than SET-M33, 2 hours versus 24 hours, and consistently it has a lower activity against Gram-negative bacteria [40] [41] . The additional Q allowed us to study the structure of all residues, including the first lysine. Q-33 did not show any stable conformation in water, but addition of SDS micelles caused a generalized dispersion of proton resonances and the emergence of NOE peaks, indicating that a stable conformer was present as a consequence of the peptidemicelle interaction. In particular, NOE signals of the Hαi-HN i+3 , Hαi-Hβ i+3 and HNi-HN i+2 types for residue i=1 to 6 are diagnostic of α-helix conformation spanning residues 1-9 ( Figure 5A ). Peak integration of a total set of 32 NOEs allowed us to calculate the relative interproton distances, which were used as constraints for simulation of torsion angle dynamics and subsequent peptide structure calculations. The resulting structure showed a regular α-helix encompassing the full-length of the peptide. To assess the interaction geometry of the helix with SDS micelles, a paramagnetic solution-NMR experiment was performed. TOCSY (total correlation spectroscopy) spectra of the peptide-micelle system were acquired in the presence and absence of increasing concentrations of the paramagnetic probe Gd(III)(DTPA-BMA). The soluble probe causes nuclear spin relaxation proportional to the local surface accessibility of the molecule investigated [42] [43] [44] . Relaxation is measured by calculating the decrease in peak volumes on addition of the probe, and is summarized as a bare number, the attenuation value A, which ranges from 0 to 2 and can be determined for each known proton peak. Protons shielded by contact with the solvent, and therefore not accessible to the probe,
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show low A values, while exposed protons show high A values ( Figure 5B , upper part). Attenuation analysis was carried out on the Q-33-micelle system and an accurate accessibility profile was determined. Residues I3 and L7 showed much lower accessibility of the probe to their sidechains,
ACCEPTED MANUSCRIPT 17 and this can be ascribed to shielding by close interaction with the micelle surface. Charged residue pairs K1/R4 and K2/R6, situated on the opposite side of the helix, showed a higher A value, while V5 and S8 showed the highest attenuation due to their high exposure to the solvent. The resulting structure was a helix lying on the micelle surface with I3/L7 sidechains inserted into the SDS assembly, and R and K sidechains arranged parallel to the surface, their charged tips interacting with the negative sulfate groups ( Figure 5B ). This facial amphiphilic structure has already been reported for other positively charged peptides [45] , such as LL37 fragments [46] and CRAMP [47] .
Finally, we wanted to assess whether SET-M33 and Q-33 had the same ability to adopt a helix conformation in a membrane mimicking environment, using circular dichroism. The technique proved to be applicable to both the tetrabranched and the linear peptide. SET-M33 and Q-33 CD spectra were recorded at room temperature in water and in SDS 30 mM. In line with the NMR experiments, SET-M33 showed a non-structured conformation in water but the CD spectrum shifted sharply to longer wavelengths in the presence of SDS micelles ( Figure 5C ), and the calculated helix ratio switched from 0% to 30%. A similar result was obtained with Q-33 ( Figure 5D ): the spectra recorded in water had a calculated helix ratio of 3.3% compared to 39% in the presence of SDS micelles. The CD spectra of SET-M33 and Q-33, recorded with or without micelles, were very similar, confirming that Q-33 was a reliable model of SET-M33 for the NMR experiments.
Selectivity / hemolytic activity
The ability of cationic peptides to stabilize as an α-helix, and particularly as a facial amphiphilic structure, is often associated with self-aggregation and undesired peptide interactions with blood proteins due to exposed hydrophobic surfaces [45] . The tendency to self-aggregate is correlated to hydrophobicity and provides an indirect estimate of the propensity for partitioning into lipid membranes with unselective detergent-like characteristics. Antimicrobial peptides need to be selective for prokaryotic membranes; a well-established method of verifying their ability to damage eukaryotic cell membranes is to measure their hemolytic activity [48] . Our results showed that red blood cells incubated with increasing concentrations of SET-M33 did not show more than 26% lysis, even using a concentration of 1.8 mg/ml (320 µM), which is more than 100-fold the MIC ( Figure 6 ). In contrast with other cationic peptides [49] , SET-M33 showed very little hemolytic activity against red blood cells, although it shares the ability to form a regular α-helix shape. Indeed, SET-M33 also proved not to be cytotoxic to human bronchial epithelial cells (16HBE14 and CFBE41) [23] . Selfaggregation, often associated with amphiphilic structures and undesired secondary effects [49] , was also studied in FPLC experiments (Supplementary material - Figure 1S , A) and showed that no self-aggregation occurred when SET-M33 was dissolved in PBS. The presence of LPS promoted the formation of high-mass hetero-multimers, but not homo-multimers (Supplementary material - Figure 1S , B), in line with what we observed and described above in relation to SDS.
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Conclusions
Current understanding of the mechanism of action of cationic AMPs includes a first step of electrostatic attraction between the cationic peptide and the negatively charged bacterial outer membrane. As SET-M33 is a cationic amphiphilic peptide it is attracted to the negatively charged bacterial membrane. Once close to the microbial surface, AMPs need to cross the polysaccharide cell wall barrier before interacting with the cytoplasmic membrane [15, [50] [51] . In line with this, in previous studies, SET-M33 was shown, by surface plasmon resonance, to bind LPS of K.
pneumoniae and P. aeruginosa [52] and the binding prevented TNF- release, neutralizing endotoxin activity in vitro and in vivo [22, 41] . In the present study, NMR investigation of Q-33/SDS micelles in solution and in the presence of a paramagnetic probe showed that the α-helix arranges itself on the surface of micelles as previously described for other antimicrobial peptides [53] [54] [55] . Though direct measurement of the geometry of SET-M33/SDS micelle interactions was A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 19 not possible, we demonstrated with CD that the structural transition observed using Q-33/SDS micelles also occurs using the original tetra-branched SET-M33 peptide. The α-helix showed to be partially buried in the lipid-bilayer. In the course of 15-60 minutes, the signs of membrane damages are, indeed, evident in electron microscopy. We also knew that SET-M33 is internalized in E. Coli within 5 minutes, proving that it can cross cell wall and plasma membranes [41] , causing enhanced membrane permeability, as observed with fluorescent probes [41] . Bacteria death may realistically be caused by impairment of the membrane homeostasis and functionality.
Interestingly, SET-M33 is different from other α-helix antimicrobial peptides in that it shows little propensity to self-aggregate and also no hemolytic activity. Homo-aggregation, which is considered related with undesired toxicity [48] [49] , is never observed. This aspect probably contributes in preventing non-specific interactions with eukaryotic cells [48] [49] and indeed correlates with an acceptable tolerability profile obtained in toxicology studies in mice [21] .
SET-M33 does not show any cross-resistance with colistin in colistin-resistant bacteria and, differently from colistin, it appears to generate substantially no resistance within 24 hours of exposure in extensively resistant isolates of K. pneumoniae and P. aeruginosa. These observations suggest that the two peptides have a different mechanism of action. SET-M33 is attracted onto the surface of bacteria by the anionic charges of the cell wall. Being the core of the branched peptide completely flexible, we speculate that in the presence of phospholipid-bilayers, the peptide can assume a star like conformation, where hydrophobic residues are buried in the surface and hydrophilic residues point outwards. The disturbance of bi-layers integrity, produced by SET-M33's peculiar way to interact with membranes, makes it more difficult for bacteria to trigger resistance mechanisms than it is for colistin.
Finally SET-M33, in contrast to other similar antimicrobial peptides such as colistin, does not generate resistant mutants after 24 h of exposure, and non-specific interactions or toxicity against eukaryotic cell membranes, suggesting that SET-M33 is a promising new option for the treatment of Gram-negative antibiotic-resistant infections.
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